Emerging roles for the TGFβ family in pancreatic β-cell homeostasis

Trends in Endocrinology and Metabolism

Volumn 21, Issue 7, 2010, Pages 441-448

  Brown, Melissa L ^a   Schneyer, Alan L ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN 4; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR; MYOSTATIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; GLUCOSE;

CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; GENE SILENCING; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; HUMAN; HYPERINSULINEMIA; HYPERPLASIA; HYPOPLASIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; ARTICLE; HOMEOSTASIS; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; INSULIN-SECRETING CELLS; MICE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77954312234     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2010.02.008     Document Type: Review

References (59)

1. Saxena, R. et al. and the Diabetes Genetics Initiative (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336.
2. Simonis-Bik A.M., et al. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A and MTNR1B affect different aspects of pancreatic beta cell function. Diabetes 2010, 59:293-301.
3. Staiger H., et al. Pathomechanisms of type 2 diabetes genes. Endocr. Rev. 2009, 30:557-585.
4. Oliver-Krasinski J.M., Stoffers D.A. On the origin of the β cell. Genes Dev. 2008, 22:1998-2021.
5. Massague J. TGFβ in Cancer. Cell 2008, 134:215-230.
6. Pangas S.A., Woodruff T.K. Activin signal transduction pathways. Trends Endocrinol. Metab. 2000, 11:309-314.
7. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
8. Nickel J., et al. Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev. 2009, 20:367-377.
9. Andersson O., et al. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep. 2006, 7:831-837.
10. Welt C., et al. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp. Biol. Med. (Maywood) 2002, 227:724-752.
11. Kumar M., et al. Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev. Biol. 2003, 259:109-122.
12. Kim S.K., MacDonald R.J. Signaling and transcriptional control of pancreatic organogenesis. Curr. Opin. Genet. Dev. 2002, 12:540-547.
13. Kordowich S., et al. Reprogramming into pancreatic endocrine cells based on developmental cues. Mol. Cell. Endocrinol. 2010, 315:11-18.
14. Collombat P., et al. Specifying pancreatic endocrine cell fates. Mech. Dev. 2006, 123:501-512.
15. Wada M., et al. Immunohistochemical localization of activin A and follistatin in human tissues. Endocr. J. 1996, 43:375-385.
16. Ogawa K., et al. Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett. 1993, 319:217-220.
17. Yamaoka T., et al. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J. Clin. Invest 1998, 102:294-301.
18. Kim S.K., et al. Activin receptor patterning of foregut organogenesis. Genes Dev. 2000, 14:1866-1871.
19. Florio P., et al. Activin A stimulates insulin secretion in cultured human pancreatic islets. J. Endocrinol. Invest 2000, 23:231-234.
20. Verspohl E.J., et al. Activin A: its effects on rat pancreatic islets and the mechanism of action involved. Life Sci. 1993, 53:1069-1078.
21. Totsuka Y., et al. A novel action of activin A: stimulation of insulin secretion in rat pancreatic islets. Biochem. Biophys. Res. Commun. 1988, 156:335-339.
22. Bertolino P., et al. Activin B receptor ALK7 is a negative regulator of pancreatic β-cell function. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7246-7251.
23. Matsuoka T.A., et al. MafA regulates expression of genes important to islet β-cell function. Mol. Endocrinol. 2007, 21:2764-2774.
24. Sosa-Pineda B. The gene Pax4 is an essential regulator of pancreatic beta-cell development. Mol. Cells 2004, 18:289-294.
25. Brun T., et al. The diabetes-linked transcription factor PAX4 promotes β-cell proliferation and survival in rat and human islets. J. Cell Biol. 2004, 167:1123-1135.
26. Brun T., Gauthier B.R. A focus on the role of Pax4 in mature pancreatic islet β-cell expansion and survival in health and disease. J. Mol. Endocrinol. 2008, 40:37-45.
27. Goto Y., et al. Genetic interactions between activin type IIB receptor and Smad2 genes in asymmetrical patterning of the thoracic organs and the development of pancreas islets. Dev. Dyn. 2007, 236:2865-2874.
28. Shiozaki S., et al. Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor. Biochim. Biophys. Acta 1999, 1450:1-11.
29. Li L., et al. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 2004, 53:608-615.
30. Bernard D.J., et al. Activin B can signal through both ALK4 and ALK7 in gonadotrope cells. Reprod. Biol. Endocrinol. 2006, 4:52.
31. Watanabe R., et al. Insulin gene is a target in activin receptor-like kinase 7 signaling pathway in pancreatic β-cells. Biochem. Biophys. Res. Commun. 2008, 377:867-872.
32. Yasuda H., et al. Existence of activin-A in A- and D-cells of rat pancreatic islet. Endocrinology 1993, 133:624-630.
33. Mamin A., Philippe J. Activin A decreases glucagon and arx gene expression in α cell lines. Mol. Endocrinol. 2006, 21:259-273.
34. Collombat P., et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009, 138:449-462.
35. Zhang Y.Q., et al. Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic beta-cells. Diabetes 2004, 53:2024-2033.
36. Park M.K., et al. Effects of activin A on pancreatic ductal cells in streptozotocin-induced diabetic rats. Transplantation 2007, 83:925-930.
37. Inada A., et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19915-19919.
38. Solar M., et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev. Cell 2009, 17:849-860.
39. Xu X., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132:197-207.
40. Yamanaka Y., et al. Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes. 1993, 42:746-756.
41. Brorson M., et al. Expression of SMAD signal transduction molecules in the pancreas. Histochem. Cell Biol. 2001, 116:263-267.
42. Totsuka Y., et al. Stimulation of insulin secretion by transforming growth factor-beta. Biochem. Biophys. Res. Commun. 1989, 158:1060-1065.
43. Sjoholm A., Hellerstrom C. TGF-beta stimulates insulin secretion and blocks mitogenic response of pancreatic beta-cells to glucose. Am. J. Physiol. Cell Physiol. 1991, 260:C1046-C1051.
44. Sayo Y., et al. Transforming growth factor beta induction of insulin gene expression is mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. Eur. J. Biochem. 2000, 267:971-978.
45. Lin H.M., et al. Transforming growth factor-β/Smad3 signaling regulates insulin gene transcription and pancreatic islet β-cell function. J. Biol. Chem. 2009, 284:12246-12257.
46. Grewal I.S., et al. Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J. Autoimmun. 2002, 19:9-22.
47. Lee M.S., et al. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am. J. Pathol. 1995, 147:42-52.
48. Moritani M., et al. Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-β1. Mol. Cell Endocrinol. 2005, 229:175-184.
49. Smart N.G., et al. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol. 2006, 4:e39.
50. + islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development 2004, 131:6163-6174.
51. McPherron A.C., Lee S.J. Suppression of body fat accumulation in myostatin-deficient mice. J. Clin. Invest. 2002, 109:595-601.
52. McPherron A.C., et al. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
53. Guo T., et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009, 4:e4937.
54. Goulley J., et al. BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion. Cell Metab. 2007, 5:207-219.
55. Tortoriello D.V., et al. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 2001, 142:3426-3434.
56. Sidis Y., et al. Biological activity of follistatin isoforms and follistatin like-3 are dependent on differential cell surface binding and specificity for activin, myostatin and BMPs. Endocrinology 2006, 147:3586-3597.
57. Schneyer A.L., et al. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology 2008, 149:4589-4595.
58. Mukherjee A., et al. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1348-1353.
59. Matzuk M.M., et al. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995, 374:360-363.